Report Detail

Request for Sample of this report

Pharma & Healthcare Global CRISPR And CRISPR-Associated (Cas) Genes Market Growth 2019-2024

  • RnM2988714
    • |
  • 20 February, 2019
    • |
  • Global
    • |
  • 160 Pages
    • |
  • LPI(LP Information)
    • |
  • Pharma & Healthcare

Clustered regularly interspaced short palindromic repeats (CRISPR) are segments of prokaryotic DNA containing short repetitions of base sequences. Each repetition is followed by short segments of "spacer DNA" from previous exposures to a bacteriophage virus or plasmid.
The CRISPR/Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages, and provides a form of acquired immunity. CRISPR associated proteins (Cas) use the CRISPR spacers to recognize and cut these exogenous genetic elements in a manner analogous to RNA interference in eukaryotic organisms. CRISPRs are found in approximately 40% of sequenced bacterial genomes and 90% of sequenced archaea.

CRISPR And CRISPR-Associated (Cas) Genes industry is relatively concentrated, manufacturers are mostly in the Europe and North America. Among them, North America region accounted for more than 45.70% of the total market of global CRISPR And CRISPR-Associated (Cas) Genes.
Although this market has great potential for future development, we do not recommend entering the market for investors who do not have strong capital or do not have key technology.

According to this study, over the next five years the CRISPR And CRISPR-Associated (Cas) Genes market will register a 39.8% CAGR in terms of revenue, the global market size will reach US$ 2640 million by 2024, from US$ 350 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in CRISPR And CRISPR-Associated (Cas) Genes business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of CRISPR And CRISPR-Associated (Cas) Genes market by product type, application, key manufacturers and key regions and countries.

This study considers the CRISPR And CRISPR-Associated (Cas) Genes value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Genome Editing
Genetic engineering
gRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Caribou Biosciences
Addgene
CRISPR THERAPEUTICS
Merck KGaA
Mirus Bio LLC
Editas Medicine
Takara Bio USA
Thermo Fisher Scientific
Horizon Discovery Group
Intellia Therapeutics
GE Healthcare Dharmacon

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global CRISPR And CRISPR-Associated (Cas) Genes consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of CRISPR And CRISPR-Associated (Cas) Genes market by identifying its various subsegments.
Focuses on the key global CRISPR And CRISPR-Associated (Cas) Genes manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the CRISPR And CRISPR-Associated (Cas) Genes with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of CRISPR And CRISPR-Associated (Cas) Genes submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.


Table of Contents

    2019-2024 Global CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Report

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global CRISPR And CRISPR-Associated (Cas) Genes Consumption 2014-2024
        • 2.1.2 CRISPR And CRISPR-Associated (Cas) Genes Consumption CAGR by Region
      • 2.2 CRISPR And CRISPR-Associated (Cas) Genes Segment by Type
        • 2.2.1 Genome Editing
        • 2.2.2 Genetic engineering
        • 2.2.3 gRNA Database/Gene Librar
        • 2.2.4 CRISPR Plasmid
        • 2.2.5 Human Stem Cells
        • 2.2.6 Genetically Modified Organisms/Crops
        • 2.2.7 Cell Line Engineering
      • 2.3 CRISPR And CRISPR-Associated (Cas) Genes Consumption by Type
        • 2.3.1 Global CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Type (2014-2019)
        • 2.3.2 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue and Market Share by Type (2014-2019)
        • 2.3.3 Global CRISPR And CRISPR-Associated (Cas) Genes Sale Price by Type (2014-2019)
      • 2.4 CRISPR And CRISPR-Associated (Cas) Genes Segment by Application
        • 2.4.1 Biotechnology Companies
        • 2.4.2 Pharmaceutical Companies
        • 2.4.3 Academic Institutes
        • 2.4.4 Research and Development Institutes
      • 2.5 CRISPR And CRISPR-Associated (Cas) Genes Consumption by Application
        • 2.5.1 Global CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Application (2014-2019)
        • 2.5.2 Global CRISPR And CRISPR-Associated (Cas) Genes Value and Market Share by Application (2014-2019)
        • 2.5.3 Global CRISPR And CRISPR-Associated (Cas) Genes Sale Price by Application (2014-2019)

      3 Global CRISPR And CRISPR-Associated (Cas) Genes by Players

      • 3.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Players
        • 3.1.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales by Players (2017-2019)
        • 3.1.2 Global CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Players (2017-2019)
      • 3.2 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue Market Share by Players
        • 3.2.1 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue by Players (2017-2019)
        • 3.2.2 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue Market Share by Players (2017-2019)
      • 3.3 Global CRISPR And CRISPR-Associated (Cas) Genes Sale Price by Players
      • 3.4 Global CRISPR And CRISPR-Associated (Cas) Genes Manufacturing Base Distribution, Sales Area, Product Types by Players
        • 3.4.1 Global CRISPR And CRISPR-Associated (Cas) Genes Manufacturing Base Distribution and Sales Area by Players
        • 3.4.2 Players CRISPR And CRISPR-Associated (Cas) Genes Products Offered
      • 3.5 Market Concentration Rate Analysis
        • 3.5.1 Competition Landscape Analysis
        • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.6 New Products and Potential Entrants
      • 3.7 Mergers & Acquisitions, Expansion

      4 CRISPR And CRISPR-Associated (Cas) Genes by Regions

      • 4.1 CRISPR And CRISPR-Associated (Cas) Genes by Regions
        • 4.1.1 Global CRISPR And CRISPR-Associated (Cas) Genes Consumption by Regions
        • 4.1.2 Global CRISPR And CRISPR-Associated (Cas) Genes Value by Regions
      • 4.2 Americas CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth
      • 4.3 APAC CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth
      • 4.4 Europe CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth
      • 4.5 Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth

      5 Americas

      • 5.1 Americas CRISPR And CRISPR-Associated (Cas) Genes Consumption by Countries
        • 5.1.1 Americas CRISPR And CRISPR-Associated (Cas) Genes Consumption by Countries (2014-2019)
        • 5.1.2 Americas CRISPR And CRISPR-Associated (Cas) Genes Value by Countries (2014-2019)
      • 5.2 Americas CRISPR And CRISPR-Associated (Cas) Genes Consumption by Type
      • 5.3 Americas CRISPR And CRISPR-Associated (Cas) Genes Consumption by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC CRISPR And CRISPR-Associated (Cas) Genes Consumption by Countries
        • 6.1.1 APAC CRISPR And CRISPR-Associated (Cas) Genes Consumption by Countries (2014-2019)
        • 6.1.2 APAC CRISPR And CRISPR-Associated (Cas) Genes Value by Countries (2014-2019)
      • 6.2 APAC CRISPR And CRISPR-Associated (Cas) Genes Consumption by Type
      • 6.3 APAC CRISPR And CRISPR-Associated (Cas) Genes Consumption by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe CRISPR And CRISPR-Associated (Cas) Genes by Countries
        • 7.1.1 Europe CRISPR And CRISPR-Associated (Cas) Genes Consumption by Countries (2014-2019)
        • 7.1.2 Europe CRISPR And CRISPR-Associated (Cas) Genes Value by Countries (2014-2019)
      • 7.2 Europe CRISPR And CRISPR-Associated (Cas) Genes Consumption by Type
      • 7.3 Europe CRISPR And CRISPR-Associated (Cas) Genes Consumption by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes by Countries
        • 8.1.1 Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Consumption by Countries (2014-2019)
        • 8.1.2 Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Value by Countries (2014-2019)
      • 8.2 Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Consumption by Type
      • 8.3 Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Consumption by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Marketing, Distributors and Customer

      • 10.1 Sales Channel
        • 10.1.1 Direct Channels
        • 10.1.2 Indirect Channels
      • 10.2 CRISPR And CRISPR-Associated (Cas) Genes Distributors
      • 10.3 CRISPR And CRISPR-Associated (Cas) Genes Customer

      11 Global CRISPR And CRISPR-Associated (Cas) Genes Market Forecast

      • 11.1 Global CRISPR And CRISPR-Associated (Cas) Genes Consumption Forecast (2019-2024)
      • 11.2 Global CRISPR And CRISPR-Associated (Cas) Genes Forecast by Regions
        • 11.2.1 Global CRISPR And CRISPR-Associated (Cas) Genes Forecast by Regions (2019-2024)
        • 11.2.2 Global CRISPR And CRISPR-Associated (Cas) Genes Value Forecast by Regions (2019-2024)
        • 11.2.3 Americas Consumption Forecast
        • 11.2.4 APAC Consumption Forecast
        • 11.2.5 Europe Consumption Forecast
        • 11.2.6 Middle East & Africa Consumption Forecast
      • 11.3 Americas Forecast by Countries
        • 11.3.1 United States Market Forecast
        • 11.3.2 Canada Market Forecast
        • 11.3.3 Mexico Market Forecast
        • 11.3.4 Brazil Market Forecast
      • 11.4 APAC Forecast by Countries
        • 11.4.1 China Market Forecast
        • 11.4.2 Japan Market Forecast
        • 11.4.3 Korea Market Forecast
        • 11.4.4 Southeast Asia Market Forecast
        • 11.4.5 India Market Forecast
        • 11.4.6 Australia Market Forecast
      • 11.5 Europe Forecast by Countries
        • 11.5.1 Germany Market Forecast
        • 11.5.2 France Market Forecast
        • 11.5.3 UK Market Forecast
        • 11.5.4 Italy Market Forecast
        • 11.5.5 Russia Market Forecast
        • 11.5.6 Spain Market Forecast
      • 11.6 Middle East & Africa Forecast by Countries
        • 11.6.1 Egypt Market Forecast
        • 11.6.2 South Africa Market Forecast
        • 11.6.3 Israel Market Forecast
        • 11.6.4 Turkey Market Forecast
        • 11.6.5 GCC Countries Market Forecast
      • 11.7 Global CRISPR And CRISPR-Associated (Cas) Genes Forecast by Type
      • 11.8 Global CRISPR And CRISPR-Associated (Cas) Genes Forecast by Application

      12 Key Players Analysis

      • 12.1 Caribou Biosciences
        • 12.1.1 Company Details
        • 12.1.2 CRISPR And CRISPR-Associated (Cas) Genes Product Offered
        • 12.1.3 Caribou Biosciences CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.1.4 Main Business Overview
        • 12.1.5 Caribou Biosciences News
      • 12.2 Addgene
        • 12.2.1 Company Details
        • 12.2.2 CRISPR And CRISPR-Associated (Cas) Genes Product Offered
        • 12.2.3 Addgene CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.2.4 Main Business Overview
        • 12.2.5 Addgene News
      • 12.3 CRISPR THERAPEUTICS
        • 12.3.1 Company Details
        • 12.3.2 CRISPR And CRISPR-Associated (Cas) Genes Product Offered
        • 12.3.3 CRISPR THERAPEUTICS CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.3.4 Main Business Overview
        • 12.3.5 CRISPR THERAPEUTICS News
      • 12.4 Merck KGaA
        • 12.4.1 Company Details
        • 12.4.2 CRISPR And CRISPR-Associated (Cas) Genes Product Offered
        • 12.4.3 Merck KGaA CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.4.4 Main Business Overview
        • 12.4.5 Merck KGaA News
      • 12.5 Mirus Bio LLC
        • 12.5.1 Company Details
        • 12.5.2 CRISPR And CRISPR-Associated (Cas) Genes Product Offered
        • 12.5.3 Mirus Bio LLC CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.5.4 Main Business Overview
        • 12.5.5 Mirus Bio LLC News
      • 12.6 Editas Medicine
        • 12.6.1 Company Details
        • 12.6.2 CRISPR And CRISPR-Associated (Cas) Genes Product Offered
        • 12.6.3 Editas Medicine CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.6.4 Main Business Overview
        • 12.6.5 Editas Medicine News
      • 12.7 Takara Bio USA
        • 12.7.1 Company Details
        • 12.7.2 CRISPR And CRISPR-Associated (Cas) Genes Product Offered
        • 12.7.3 Takara Bio USA CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.7.4 Main Business Overview
        • 12.7.5 Takara Bio USA News
      • 12.8 Thermo Fisher Scientific
        • 12.8.1 Company Details
        • 12.8.2 CRISPR And CRISPR-Associated (Cas) Genes Product Offered
        • 12.8.3 Thermo Fisher Scientific CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.8.4 Main Business Overview
        • 12.8.5 Thermo Fisher Scientific News
      • 12.9 Horizon Discovery Group
        • 12.9.1 Company Details
        • 12.9.2 CRISPR And CRISPR-Associated (Cas) Genes Product Offered
        • 12.9.3 Horizon Discovery Group CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.9.4 Main Business Overview
        • 12.9.5 Horizon Discovery Group News
      • 12.10 Intellia Therapeutics
        • 12.10.1 Company Details
        • 12.10.2 CRISPR And CRISPR-Associated (Cas) Genes Product Offered
        • 12.10.3 Intellia Therapeutics CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.10.4 Main Business Overview
        • 12.10.5 Intellia Therapeutics News
      • 12.11 GE Healthcare Dharmacon

      13 Research Findings and Conclusion

      Summary:
      Get latest Market Research Reports on CRISPR And CRISPR-Associated (Cas) Genes . Industry analysis & Market Report on CRISPR And CRISPR-Associated (Cas) Genes is a syndicated market report, published as Global CRISPR And CRISPR-Associated (Cas) Genes Market Growth 2019-2024. It is complete Research Study and Industry Analysis of CRISPR And CRISPR-Associated (Cas) Genes market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,660.00
      		$5,490.00
      		$7,320.00
      		2,876.76
      		4,315.14
      		5,753.52
      		3,458.70
      		5,188.05
      		6,917.40
      		568,032.00
      		852,048.00
      		1,136,064.00
      		309,050.40
      		463,575.60
      		618,100.80
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo